01612.HK
Vincent Medical Holdings Limited
HKSE · Healthcare · Medical - Devices · HK
HKD 0.67
−1.47%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.8B | 932.8M | 801.0M | 718.0M | 629.2M |
| Cost of Revenue | 1.2B | 605.3M | 541.0M | 477.6M | 481.4M |
| Gross Profit | 633.6M | 327.4M | 260.0M | 240.4M | 147.8M |
| Operating Expenses | |||||
| R&D Expense | 91.1M | 48.7M | 30.6M | 36.1M | 36.7M |
| SG&A Expense | 311.1M | 148.6M | 151.2M | 139.1M | 133.7M |
| General & Admin Expense | 226.0M | 106.3M | 112.0M | 99.1M | 101.7M |
| Selling & Marketing Expense | 85.8M | 43.0M | 39.2M | 38.9M | 32.0M |
| Other Expenses | (583.0K) | 400.0K | (1.5M) | (539.0K) | 6.0M |
| Total Operating Expenses | 401.5M | 197.7M | 180.3M | 174.6M | 176.4M |
| Cost and Expenses | 1.6B | 803.1M | 721.3M | 652.2M | 640.2M |
| Operating Income (EBIT) | 232.0M | 129.7M | 79.7M | 65.8M | (11.0M) |
| Non-Operating | |||||
| Interest Income | 1.3M | 1.3M | 1.2M | 697.0K | 510.0K |
| Interest Expense | 4.0M | 899.0K | 1.4M | 1.7M | 2.9M |
| Net Interest Income | (2.7M) | 405.0K | (159.0K) | (985.0K) | (2.3M) |
| Other Non-Op Income/Expense | (4.7M) | (55.0K) | (1.7M) | 1.1M | (4.5M) |
| Non-Operating Income (excl Interest) | (4.9M) | (4.3M) | 1.9M | (1.3M) | 3.5M |
| EBT (Pre-Tax Income) | 227.3M | 129.6M | 78.0M | 66.9M | (15.5M) |
| Income Tax Expense | 36.6M | 21.3M | 7.1M | 8.7M | 2.9M |
| Bottom Line | |||||
| Net Income | 183.8M | 104.4M | 69.2M | 57.3M | (17.4M) |
| Earnings from Cont. Ops | 190.7M | 108.4M | 70.9M | 58.2M | (18.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 183.8M | 104.4M | 69.2M | 57.3M | (17.4M) |
| Per Share | |||||
| Basic EPS | HK$0.28 | HK$0.16 | HK$0.11 | HK$0.09 | (HK$0.03) |
| Diluted EPS | HK$0.28 | HK$0.16 | HK$0.11 | HK$0.09 | (HK$0.03) |
| Revenue Per Share | HK$2.83 | HK$1.45 | HK$1.25 | HK$1.11 | HK$0.96 |
| Shares | |||||
| Basic Shares Outstanding | 649.4M | 645.1M | 643.3M | 645.7M | 653.7M |
| Diluted Shares Outstanding | 651.1M | 645.1M | 643.3M | 645.7M | 653.7M |
| Profitability Metrics | |||||
| EBITDA | 293.6M | 155.3M | 100.0M | 104.4M | 30.0M |
| D&A | 56.8M | 21.3M | 22.2M | 38.3M | 41.0M |
| EBIT | 236.9M | 134.0M | 77.8M | 65.8M | (11.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026